| AD | Adult Disease |
| AGREE II | The Appraisal of Guidelines for Research and Evaluation II Tool |
| ALD | Adrenoleukodystrophy |
| AMSTAR 2 | A Measurement Tool to Assess Systematic Reviews |
| ARSA | Arylsulfatase A |
| ARSA-PD | Arylsulfatase A Pseudodeficiency |
| CNS | Central Nervous System |
| DBS | Dried Blood Spot |
| DUS | Dried Urine Spot |
| EJ | Early Juvenile |
| FPR | False Positive Rate |
| GRADE | Grading of Recommendations, Assessment, Development, and Evaluation |
| HSCT | Hematopoietic Stem Cell Transplantation |
| LI | Late Infantile |
| LJ | Late Juvenile |
| LC-MS/MS | Liquid Chromatography—Tandem Mass Spectrometry |
| MLD | Metachromatic Leukodystrophy |
| MoM | Multiples of Median |
| MRI | Magnetic Resonance Imaging |
| MSD | Multiple Sulfatase Deficiency |
| NBS | Newborn Screening |
| NGS | Next Generation Sequencing |
| NOS | Newcastle–Ottawa Scale |
| QUADAS-2 | Quality Assessment of Diagnostic Accuracy Studies 2 |
| VUS | Variants of Uncertain Significance |
| WES | Whole-Exome Sequencing |